In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HLTH Corp.

www.hlth.com

Latest From HLTH Corp.

Cyberizing the Rep: Can E-Marketing Solve Pharma's Promotional Dilemma?

Drug marketing is increasingly expensive and decreasingly productive. WebMD Health, the dominant health portal, argues it is not merely another advertising forum, but a more effective influencer of consumer and physician behavior than detail reps and DTC promotion. So far, drug companies remain on the sidelines, having been burned once by similar arguments about the marketing value of neutral channels, represented by PBMs, of which many of WebMD's managers are alumnae.
BioPharmaceutical Medical Device

Quintiles Unveils Its New E-Commerce Products--But Where's WebMD?

If ever an industry needed to find new ways of marketing itself, the currently floundering CRO business certainly fills the bill. A number of industry observers and insiders argue that Internet technologies could play a crucial rule in transforming R&D outsourcing from its role as a temporary means of boosting capacity to that of drug development partners. Each of the top three CROs have, in fact, devoted significant resources to building Internet capabilities. But the most publicized and ambitious such effort from Quintiles Transnational Corp., which is attempting to leverage its substantial financial resources, as well as the advantages of having a major commercialization outsourcing business that complements its drug development operations, to create an Internet platform whose scope the competition simply cannot match.
BioPharmaceutical Business Strategies

Harnessing Interactive DTC to Drive Demand in Product Launch

Given the importance of a rapid launch of new products, many pharmaceutical firms are turning to consumer marketing tools to create consumer demand. To date, much of the consumer marketing effort has focused on direct-to-consumer advertising, but more and more drug companies are learning to harness the power of the Internet to push out their product message.Far more than simply establishing a web site, interactive DTC--or iDTC--marketing is a two-way approach whereby companies and consumers exchange information through feedback loops, the end result of which is to develop and deepen customer relationships. To be effective, however, iDTC campaigns must have a clear sense of the bottlenecks to product adoption, establish reasonable goals and expectations, and coordinate with and complement much more traditional launch strategies.
BioPharmaceutical Business Strategies

Hand-To-Hand Combat In a Crowded PDA Arena

As bleak as times may be for e-health start-ups, there's certainly no dearth of companies trying to get personal digital assistant devices into the hands of physicians. Although most of the buzz has been about e-prescribing, that's only the beginning of what start-ups aim to offer.
Business Strategies Platform Technologies
See All

Company Information

  • Industry
  • Digital Health
  • Therapeutic Areas
  • Alias(es)
  • Healtheon/WebMD Corp.
  • WebMD Corp.
  • Emdeon Corp.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • HLTH Corp.
  • Senior Management
  • Jeff Arnold, CEO
    Andrew C Corbin, EVP, CFO
    Thomas P Apker, COO
    K. Robert Draughton, EVP, Bus. Dev.
  • Contact Info
  • HLTH Corp.
    Phone: (201) 703-3400
    669 River Drive
    Center 2
    Elmwood Park, NJ 07407
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register